Caplin Point Laboratories Limited
NSE:CAPLIPOINT.NS
Overview | Financials
Company Name | Caplin Point Laboratories Limited |
Symbol | CAPLIPOINT.NS |
Currency | INR |
Price | 2,011.8 |
Market Cap | 152,920,338,060 |
Dividend Yield | 0.33% |
52-week-range | 1,111.55 - 2,176.75 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Dr. Sridhar Ganesan |
Website | https://www.caplinpoint.net |
An error occurred while fetching data.
About Caplin Point Laboratories Limited
Caplin Point Laboratories Limited develops, produces, markets, and exports generic pharmaceutical formulations and branded products in India. The company provides liquid and lyophilized injections, ophthalmic products, tablets, liquid orals, capsules, softgel capsules, suppositories and ovules, powder for injection, dry syrups, topicals, inhalers, IV infusions, lyophilized products, branded products, dermo cosmetics,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD